In NSCLC cells, LPS+ATP treatment significantly stimulated the phosphorylation of key molecules in the MAPK signaling pathway, including ERK, JNK, and p38 proteins, compared to in the non-stimulated group (p < 0.001) of NSCLC cells, as shown in Figure 10. The gene discussed is MAPK8; the disease is non-small cell lung carcinoma.